Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-25
pubmed:abstractText
Early diagnosis of hepatocellular carcinoma (HCC) is the key to the delivery of effective therapies. The conventional serological diagnostic test, estimation of serum alpha-fetoprotein (AFP) lacks both sensitivity and specificity as a screening tool and improved tests are needed to complement ultrasound scanning, the major modality for surveillance of groups at high risk of HCC. We have analysed the serum proteome of 182 patients with hepatitis C-induced liver cirrhosis (77 with HCC) by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI). The patients were split into a training set (84 non-HCC, 60 HCC) and a 'blind' test set (21 non-HCC, 17 HCC). Neural networks developed on the training set were able to classify the blind test set with 94% sensitivity (95% CI 73-99%) and 86% specificity (95% CI 65-95%). Two of the SELDI peaks (23/23.5 kDa) were elevated by an average of 50% in the serum of HCC patients (P<0.001) and were identified as kappa and lambda immunoglobulin light chains. This approach may permit identification of several individual proteins, which, in combination, may offer a novel way to diagnose HCC.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-11385503, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-11592607, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-11668491, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-11922571, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-12097261, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-12142387, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-12394209, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-12709366, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-12834318, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-14751995, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-15057290, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-15313933, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-15623616, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-15690480, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-15726646, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-1847790, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-8594428, http://linkedlifedata.com/resource/pubmed/commentcorrection/16404431-9197213
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
287-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:16404431-Amino Acid Sequence, pubmed-meshheading:16404431-Base Sequence, pubmed-meshheading:16404431-Carcinoma, Hepatocellular, pubmed-meshheading:16404431-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:16404431-Hepatitis C, pubmed-meshheading:16404431-Humans, pubmed-meshheading:16404431-Immunoglobulin G, pubmed-meshheading:16404431-Liver Cirrhosis, pubmed-meshheading:16404431-Liver Neoplasms, pubmed-meshheading:16404431-Molecular Sequence Data, pubmed-meshheading:16404431-Neural Networks (Computer), pubmed-meshheading:16404431-Proteins, pubmed-meshheading:16404431-Proteome, pubmed-meshheading:16404431-ROC Curve, pubmed-meshheading:16404431-Sensitivity and Specificity, pubmed-meshheading:16404431-Spectrometry, Mass, Matrix-Assisted Laser..., pubmed-meshheading:16404431-Tumor Markers, Biological
pubmed:year
2006
pubmed:articleTitle
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.
pubmed:affiliation
Cancer Research UK Institute for Cancer Studies, School of Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't